Advances in Hematological Malignancies
Recent years have witnessed remarkable strides in the domain of hematological malignancies. Novel therapies such as targeted drugs, immunotherapies, and gene editing are revolutionizing the survival rates for patients with blood cancers. Clinical trials continue to explore these innovative approaches, offering promise for more curative treatment op